Astellas Pharma
Asia, Tokyo, Japan, Tokyo
Description
Astellas Pharma is a global pharmaceutical research & development company.
Investor Profile
Astellas Pharma has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 43% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Corporate Round, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Series A (29%)
- Corporate Round (29%)
- Series Unknown (14%)
- Series D (14%)
- Grant (14%)
Country Focus
- United States (86%)
- United Kingdom (14%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Biopharma
- Education
- Health Diagnostics
- Oncology
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
